Anti-Infective Applications of Interferon-Gamma

H.S. Jaffe, L.R. Bucalo and S.A. Sherwin

The interferons - a clinical overview, Howard S. Jaffe. Part 1 Target populations: interferon-gamma treatment of chronic granulomatous disease, Allen E. Izu, et al; infection associated with the surgical care of the major trauma victim, Hiram C. Polk, et al; potential role of interferon-gamma in human immunodeficiency virus-associated disease, David Aboulafia and Ronald T. Mitsuyasu; interferon-gamma in the neonate, Harry R. Hill; atopic dermatitis, Mark Boguniewicz and Donald Leung. Part 2 Target infections: protozoan infections - the role of interferon-gamma in resistance against toxoplasma gondii, Carlos S. Subauste and Jack S. Remington, leishmaniasis and interferon-gamma, Susan M. Kramer, interferon-gamma in trypanosoma cruzi infections, Steven G. Reed and Joao Santana da Silva, interferon-gamma and immunity to malaria sporozoites - implications for the development of synthetic vaccines, Louis Schofield; viral infections - interferon-gamma for human papillomavirus infection, Philip Kirby and Lawrence Corey, herpes simplex as a target for anti-infective applications of interferon-gamma - perclinical in vitro and in vivo observations, Ann M. Arvin, the role of interferon in cytomegalovirus infection, Richard C. Gehrz, interferons and Epstein-Barr virus infection, Motohiko Okano and David T. Purtilo; bacterial infections - treatment of lepromatous leprosy within recombinant interferon-gamma, Carl F. Nathan, interferon-gamma and the control of intracellular chlamydia replication, Gerald I. Byrne and Julius Schachter, influence of interferon-gamma on legionella pneumophilia - mononuclear phagocyte interaction, Marcus A. Horwitz; fungal infections - interferon-gamma and fungal infections, David A. Stevens. Part 3 Target treatment strategies: interferon-gamma as an adjuvant for vaccines, A.W. Heath and J.H.L. Playfair.